Literature DB >> 103726

Determination of microsomal UDP-glucuronyltransferase in needle-biopsy specimens of human liver.

K W Bock, G Brunner, H Hoensch, E Huber, D Josting.   

Abstract

Sensitive, reliable and convenient assays are described for the study of human liver microsomal UDP-glucuronyltransferase. Using 14C-1-naphthol as substrate about 2 mg of a liver biopsy specimen and for 14C-morphine about 20 mg of tissue will suffice for enzyme estimation. Lack of inhibition of 1-naphthol glucuronidation by morphine suggests that the substrates are glucuronidated by different forms of the enzyme. Enzyme levels in the native and activated state were studied in biopsies from patients grouped according to histopathological and clinical criteria. The enzyme assays may help to characterize UDP-glucuronyltransferases in human tissues and their induction by drugs and environmental chemicals, as well as their alteration in various diseases.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 103726     DOI: 10.1007/bf00611908

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  29 in total

1.  SPECTROFLUOROMETRIC DETERMINATION OF BETA-GLUCURONIDASE ACTIVITY.

Authors:  M A VERITY; R CAPER; W J BROWN
Journal:  Arch Biochem Biophys       Date:  1964-07-20       Impact factor: 4.013

2.  Chloramphenicol in the newborn infant. A physiologic explanation of its toxicity when given in excessive doses.

Authors:  C F WEISS; A J GLAZKO; J K WESTON
Journal:  N Engl J Med       Date:  1960-04-21       Impact factor: 91.245

3.  Decrease of total serum-bilirubin concentration in newborn infants after phenobarbitone treatment.

Authors:  D Trolle
Journal:  Lancet       Date:  1968-09-28       Impact factor: 79.321

4.  [Conjugation of bilirubin--enzymatic aspects].

Authors:  K W Bock
Journal:  Verh Dtsch Ges Inn Med       Date:  1976

5.  Glucuronidation of paracetamol, morphine and 1-naphthol in the rat intestinal loop.

Authors:  D Josting; D Winne; K W Bock
Journal:  Biochem Pharmacol       Date:  1976-03-01       Impact factor: 5.858

6.  Deleterious effects of subacute carbon disulphide exposure on mouse liver.

Authors:  J Järvisalo; J Kilpiö; E Elovaara; H Vainio
Journal:  Biochem Pharmacol       Date:  1977-08-15       Impact factor: 5.858

7.  Urinary excretion of morphine and its metabolites in morphine-dependent subjects.

Authors:  S Y Yeh
Journal:  J Pharmacol Exp Ther       Date:  1975-01       Impact factor: 4.030

8.  Morphine metabolism. V. Isolation of separate glucuronyltransferase activities for morphine and p-nitrophenol from rabbit liver microsomes.

Authors:  E D Villar; E Sanchez; T R Tephly
Journal:  Drug Metab Dispos       Date:  1977 May-Jun       Impact factor: 3.922

9.  UDP-glucuronyltransferase in perfused rat liver and in microsomes. Effects of CCl4 injury.

Authors:  K W Bock; E Huber; W Schlote
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-02       Impact factor: 3.000

10.  Purification and properties of microsomal UDP-glucuronosyltransferase from rat liver.

Authors:  J P Gorski; C B Kasper
Journal:  J Biol Chem       Date:  1977-02-25       Impact factor: 5.157

View more
  10 in total

1.  Cloning of a human liver microsomal UDP-glucuronosyltransferase cDNA.

Authors:  M R Jackson; L R McCarthy; D Harding; S Wilson; M W Coughtrie; B Burchell
Journal:  Biochem J       Date:  1987-03-01       Impact factor: 3.857

2.  Cloning and substrate specificity of a human phenol UDP-glucuronosyltransferase expressed in COS-7 cells.

Authors:  D Harding; S Fournel-Gigleux; M R Jackson; B Burchell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

3.  Conjugation pathways in liver disease.

Authors:  G M Pacifici; A Viani; M Franchi; S Santerini; A Temellini; L Giuliani; M Carrai
Journal:  Br J Clin Pharmacol       Date:  1990-09       Impact factor: 4.335

4.  Distribution of UDP-glucuronyltransferase in different human foetal tissues.

Authors:  G M Pacifici; A Rane
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

5.  Oral morphine in cancer patients: in vivo kinetics and in vitro hepatic glucuronidation.

Authors:  J Säwe; L Kager; J O Svensson Eng; A Rane
Journal:  Br J Clin Pharmacol       Date:  1985-04       Impact factor: 4.335

6.  Relationship between plasma concentrations of morphine and its metabolites and pain in cancer patients.

Authors:  Tomoya Sakurada; Shinya Takada; Hisae Eguchi; Keishiro Izumi; Nobunori Satoh; Shiro Ueda
Journal:  Pharm World Sci       Date:  2010-08-21

7.  Profile of drug metabolizing enzymes in the nuclear and microsomal fractions from rat liver nodules and normal liver.

Authors:  G M Pacifici; L C Eriksson; H Glaumann; A Rane
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

8.  Induction of cytochrome P-448 iso-enzymes and related glucuronyltransferases in the human liver by cigarette smoking.

Authors:  R Fleischmann; H Remmer; U Stärz
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

9.  Distribution of UDP-glucuronosyltransferase and its endogenous substrate uridine 5'-diphosphoglucuronic acid in human tissues.

Authors:  M Cappiello; L Giuliani; G M Pacifici
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

10.  Morphine glucuronidation in human fetal and adult liver.

Authors:  G M Pacifici; J Säwe; L Kager; A Rane
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.